MOL 23473
Introduction T-type, or low-voltage activated, calcium channels are characterized by a low threshold of activation, a small unitary conductance, and slow deactivation (Fox et al., 1987a; Fox et al., 1987b; Perez-Reyes, 2003) . T-channels can be blocked or otherwise modulated by multiple classes of drugs, including antiepileptics, antihypertensives, and anesthetics (Heady et al., 2001) . Verapamil is a clinically used phenylalkylamine antihypertensive that is thought to be somewhat selective for L-type calcium channels in native tissues, with estimated IC 50 ' s ranging from 600 nM in vascular smooth muscle (Kuga et al., 1990 ) to 3 µ M in ventricular myocytes (Nawrath and Wegener, 1997) .
However, the much greater IC 50 values of 40.5 µ M (Dilmac et al., 2004) and 120 µ M (Motoike et al., 1999) reported for L-type channels in heterologous expression systems, suggest that the actual affinities in vivo may be somewhat lower. Verapamil has also been shown to block T-channels, with IC 50 values of 30 µ M in vascular smooth muscle (Kuga et al., 1990 ) and 70 µ M in spermatogenic cells (Arnoult et al., 1998) . T-channels, like L-channels, appear to be blocked in a state-dependent manner (Dilmac et al., 2004; Heady et al., 2001; Motoike et al., 1999; Nawrath and Wegener, 1997) . Because Tchannel blockade has been implicated in the reduction of vascular tone in vitro (Boulanger et al., 1994; Jensen et al., 2004; Karila-Cohen et al., 1996; Lam et al., 1998; VanBavel et al., 2002) , the interactions of verapamil with this channel may prove to be therapeutically relevant.
Selective stabilization of an inactivated state is the most widely accepted explanation of how verapamil inhibits currents in L-type channels. Block of L-type current is accompanied by prominent use-dependence, slowing of recovery kinetics, This article has not been copyedited and formatted. The final version may differ from this version. and shift of the steady-state inactivation curve to hyperpolarized potentials (Dilmac et al., 2004; Nawrath and Wegener, 1997) . Multiple pore-lining residues of the L-type channel have been implicated in phenylalkylamine binding (Dilmac et al., 2004; Hockerman et al., 1997; Hockerman et al., 1995; Johnson et al., 1996; Motoike et al., 1999) , suggesting that the high-affinity binding site is located in the pore.
As is the case for many T-channel blockers, the detailed process by which verapamil inhibits T-channel currents is not known. In the present study, we have sought to elucidate the mechanism by which verapamil blocks the T-type calcium channel. We expressed a common splice variant of the human Ca v 3.1 T-type channel in HEK-293 cells and examined the effects of verapamil on macroscopic and gating currents. The drug blocked macroscopic currents at micromolar concentrations, but did not affect current time course. Verapamil slowed recovery from inactivation, and blocked current in a use-and holding potential dependent fashion. The drug competed with the permeant ion, suggesting that it bound in the pore. However, block was unaffected by the current-eliciting potential. Ca V 3.1 gating currents were also unaltered in the presence of verapamil, suggesting that the drug does not affect normal gating of the channel despite its ability to inhibit ionic currents. This finding, along with our macroscopic data, strongly suggests that verapamil inhibits currents by occlusion of the conduction pathway in open and inactivated conformations of the channel.
This article has not been copyedited and formatted. The final version may differ from this version. 
Materials and Methods

Heterologous Expression
The cDNA of a Ca v 3.1 splice variant (217) 
Solutions and Chemicals
Bath solutions for ionic current experiments contained (in mM): 2 CaCl 2 , 140
NaCl, 10 HEPES, and were titrated to pH 7.4 with 1 N NaOH. The pH 7.4 pipette solution contained (in mM): 130 NaCl, 10 HEPES, 5 MgATP, 1 CaCl 2 , 11 EGTA, titrated to pH 7.4 with 1 N NaOH. For experiments at pH 6.1, HEPES was reduced to 5 mM, EGTA was reduced to 1 mM, and 5 mM MES was added to the solution. In some experiments, the pipette solution additionally contained 500 µM Na-BAPTA, which improved seal resistances. Addition of Na-BAPTA had no effect on channel properties.
The gating current bath solution contained (in mM): 140 NMDG, 10 HEPES, 2 CaCl 2 , 2
This article has not been copyedited and formatted. The final version may differ from this version. (20-26 °C) . Currents were additionally filtered at 1 kHz offline. Drug was applied to a single chamber bath in which solutions were exchanged using the cFLOW perfusion system (Cell Microcontrols, Virginia Beach, VA) or the SF77 Perfusion Fast-
Step system (Warner Instruments, Hamden, CT). Both methods of drug application yielded similar steady-state results.
Gating currents were recorded in whole-cell mode using an Axopatch 200B feedback amplifier with a National Instruments digital-to-analog converter and LabView
Results
Verapamil Affinity for Cloned T-type and L-type Channels Is Comparable
We studied the splice variant of Ca V 3.1 that is most abundantly expressed in adult human brain. It differs from the original clone (Perez-Reyes et al., 1998) in that it is human and includes one additional exon (14), a short segment in the domain I-II linker. It is electrophysiologically similar to the clone without exon 14 (Proteins paper in press). By expressing this channel in a heterologous system, we were able to determine verapamil affinity with minimal interference by other conductances. We estimated a lower bound for verapamil affinity by measuring inhibition of peak currents under conditions in which channels were fully available at the holding potential, fully activated at the current-eliciting potential, and the duration between consecutive pulses was long. Channels depolarized from -130 mV to -10 mV at a frequency of 0. (Dilmac et al., 2004; Motoike et al., 1999) , and similar to the values previously reported for T-channels in native tissues (Arnoult et al., 1998; Kuga et al., 1990) . The experimental data were fit well by a single-site binding curve, suggesting that drug binding was not a cooperative process (Fig. 1) . Although verapamil has been reported to speed decay of L-type currents (Dilmac et al., 2004; Hockerman et al., 1997; Hockerman et al., 1995; Johnson et al., 1996; Motoike et al., 1999; Nawrath and Wegener, 1997), it did not affect the T-channel current time course.
Block Was Use-Dependent
Many calcium channel blockers more effectively inhibit currents when channels are depolarized at high frequencies ( Fig. 2) , as a result of enhanced access to highaffinity binding states. It has been reported that verapamil exhibits such use-dependent block of T-channels (Arnoult et al., 1998) in mouse spermatogenic cells, but not in rat aortic smooth muscle cells (Kuga et al., 1990) . In order to assess whether verapamil blocks the cloned channel in a use-dependent fashion, we subjected cells to trains of 100 ms steps to -10 mV interspersed by variable duration hyperpolarizations to -130 mV. 10 µ M verapamil blocked ~25% of the peak current when channels recovered for either 9900 ms or 4900 ms between consecutive depolarizations. When the recovery interval was reduced to 400 ms, block significantly increased to 51%, and verapamil blocked 69% of the peak current when channels were allowed to recover for only 100 ms between depolarizations. The prominent use-dependence of block indicated that verapamil preferentially bound to channel states entered upon membrane depolarization.
Verapamil Slowed Recovery from Fast Inactivation
The use-dependence of verapamil block suggested that the drug would slow the apparent rate of recovery from fast inactivation as well. We applied dual 50 ms pulses to -10 mV separated by variable duration steps to -130 mV to quantify the effect of verapamil on recovery kinetics. As expected, verapamil slowed recovery from fastinactivation in a dose-dependent manner (Fig. 3 ). In the absence of drug (control), the However, the amplitude of the slow component significantly increased, and the amplitude of the fast component significantly decreased, reflecting the increased proportion of drug-bound channels (Fig. 3, inset ).
Affinity Increased with Holding Potential
Under 0.2 Hz depolarization to -10 mV, equilibrium inhibition of peak current by µ M at -70 mV (Fig. 4A ). Because steady-state inactivation increased with holding potential as well, this finding implied that the drug targeted an inactivated state of the channel. However, because channels were exposed to drug throughout the activation, inactivation, and recovery processes, we could not rule out the possibility that enhanced block at positive potentials instead resulted from preferential binding to some other state.
In order to assess whether the holding potential effect resulted mainly from drug binding to inactivated channels, we utilized a fast perfusion system to selectively administer 10 µ M verapamil to inactivated channels. A 200 ms conditioning pulse was applied to inactivate channels in the absence of drug, followed by ~800 ms application This article has not been copyedited and formatted. The final version may differ from this version. µ M verapamil at the conditioning potential. Cells were then removed from drug and repolarized to -130 mV for 100 ms, an interval sufficient to recover a large fraction of unblocked channels but not blocked channels (Fig. 3) . A subsequent 50 ms step to -10 mV served as an assay for remaining current. In the absence of drug, the fractional availability of channels under these recording conditions (Fig. 4B ) decreased with conditioning potential at negative voltages, and plateaued at voltages positive to -70 mV. When the fast perfusion system was used to precisely control drug application ( Fig. 4C ) during the voltage protocol, verapamil more potently blocked channels at depolarized potentials, with fractional block (Fig. 4D ) tracking very tightly with channel availability (Fig. 4B ). This finding strongly suggested that the voltage-dependence of verapamil inhibition under these conditions (~1 s inactivation time) and under steadystate conditions (~5 s inactivation time) was primarily due to differential drug access to high-affinity inactivated states of the channel.
Verapamil Did Not Target the Fast-Inactivated State During Short Depolarizations
Because verapamil binding to inactivated states was substantial during prolonged depolarization, we sought to determine whether inactivated state binding was a major contributor to inhibition on the time scale of the current. To this end, we exposed cells to trains of depolarizations from -130 mV to -10 mV, for which the time at -130 mV was held constant at 200 ms across all experimental conditions, and the time at -10 mV was varied from 6 ms to 50 ms. A 6 ms step resulted in a small proportion (~10%) of channels entering the inactivated state. The proportion of channels that inactivated increased as the step duration was lengthened; a 50 ms step inactivated This article has not been copyedited and formatted. The final version may differ from this version. nearly the entire population of channels. We expected that if verapamil selectively stabilized the fast-inactivated state of the channel, the degree of block would increase with the proportion of channels entering the state during depolarization. However, oneway ANOVA indicated that there were no significant differences in the fractional block of current across step durations (Fig. 5) , demonstrating that access to the fast-inactivated state was unimportant in verapamil binding when channels were depolarized for such short durations.
Verapamil Interacted with the Permeant Ion
It has been reported that verapamil accesses its binding site from the intracellular space and binds in the pore of both L-type Ca 2+ channels and K + channels (DeCoursey, 1995; Dilmac et al., 2004; Johnson et al., 1996; Robe and Grissmer, 2000) . We hypothesized that verapamil would also bind in the pore of the T-channel, and predicted that it would compete with the permeant ion for a binding site. 
Block Was Voltage-Independent
At intracellular pH 7.4, ~94% of verapamil molecules bear a positive charge due to protonation of their tertiary amino groups (pKa 8.6, (Budavari, 1996) ). Accordingly, Given this result, we hypothesized that use-dependent block would be voltageindependent as well. To test this, we utilized a voltage protocol consisting of 100 ms steps to either -10 mV or +80 mV, followed by 100 ms repolarizations to -130 mV. As predicted, the fractional block of current by 10 µ M was unaffected by the current-eliciting voltage-step (68%±3% inhibition at -10 mV, 58%±3% inhibition at +80 mV, p > .05) (Fig. 7B) , despite the 90 mV difference in membrane potential.
The Active Form of Verapamil Was Uncharged
The voltage-independence of block was initially puzzling because of the large proportion of charged drug molecules and the probable location of the binding site within the pore of the channel. We reasoned that either the binding site was outside of the transmembrane field or that the neutral form of the drug was mainly responsible for its inhibitory effect. In order to test the latter hypothesis, we lowered intracellular pH from 7.4 to 6.1. We calculated that the resultant pH gradient from cytoplasmic space to bath caused an approximately twenty-fold increase in the intracellular concentration of charged drug, relative to the concentration at intracellular pH 7.4. Accordingly, if charged verapamil were the primary active species of drug, block at acidic pH should have been as much as twenty-fold greater than block at pH 7.4. Inconsistent with this hypothesis, verapamil blocked 45% of peak current under 0.2 Hz stimulation, less than twofold greater than the 26% block observed at intracellular pH 7.4. The moderate increase in fractional block compared to pH 7.4 suggests that the charged form may make a relatively minor contribution to the inhibitory effects of verapamil or that titration of ionizable channel residues increases affinity for the drug. Use-dependent block was not substantially altered either: under 5 Hz stimulation, verapamil blocked 72% of peak current, a value very similar to the 68% block at pH 7.4 (Fig. 8B ). Together these findings strongly suggested that the uncharged molecule was the main inhibitory species of the drug. Furthermore, the activation curve was unshifted by 10 transmembrane field, the fact that the active form of the drug is uncharged implies that block would be voltage-independent regardless of binding site location.
Channels Gated Normally In the Presence of Drug
Given the ability of verapamil to effectively inhibit ionic currents, we wanted to determine whether the drug could also modulate voltage sensor movement. Many drug classes, including dihydropyridines (Hadley and Lederer, 1995) and local anesthetics (Sheets and Hanck, 2003) , This article has not been copyedited and formatted. The final version may differ from this version. 
Discussion
T-type channels have been widely implicated in the control of vascular tone and blood pressure. Multiple studies have shown that T-channel inhibition is associated with the reduction of vascular smooth muscle tone in native tissues (Boulanger et al., 1994; Jensen et al., 2004; Karila-Cohen et al., 1996; Lam et al., 1998; VanBavel et al., 2002) .
Clinically, T-channel blockade has been implicated in the successful treatment of hypertension. Mibefradil, a selective T-channel blocker (Clozel et al., 1997; Martin et al., 2000; Mehrke et al., 1994; Mishra and Hermsmeyer, 1994) , exhibited favorable antihypertensive properties with minimal negative inotropic effects prior to its withdrawal from the market because of lethal drug interactions involving P450 cytochrome metabolism (Welker et al., 1998) .
Recently, two studies have challenged the notion that T-channel blockade promotes vasodilation. Chen et al. showed that Ca V 3.2 knockout mice paradoxically exhibited aberrant coronary arteriole constriction (Chen et al., 2003) . Upregulation of high-voltage activated Ca 2+ channels was likely not the cause of the constitutive vasoconstriction, but another compensatory mechanism may account for the unexpected Ca V 3.2 -/-phenotype. More recently, Moosmang and colleagues generated a vascular smooth muscle-specific knockout of the Ca V 1.2 L-type channel (Moosmang et al., 2003) which they reported was unresponsive to mibefradil (Moosmang et al., 2006) . Although the authors concluded that mibefradil achieves its in vivo action by blocking Ca V 1.2, T-channels are the preferential target in vitro (Boulanger et al., 1994; Jensen et al., 2004; Karila-Cohen et al., 1996; Lam et al., 1998; VanBavel et al., 2002) .
It may be that T-channels modulate L-type channel-mediated calcium influx rather than
This article has not been copyedited and formatted. The final version may differ from this version. Despite reports that verapamil is selective for L-channels, our data demonstrate that it inhibits T-channel currents in the same concentration range needed to block heterologously expressed L-type channels (Dilmac et al., 2004; Motoike et al., 1999) .
The experimental manipulations necessary to separate T-type currents from L-type currents in native tissues may account for the reported disparities in drug affinity in these studies (Kuga et al., 1990) . The ability of verapamil to inhibit both T-type and Ltype channels in approximately the same concentration range suggests that blockade of both channels may contribute to its potent therapeutic effects, including blood pressure reduction and ameloriation of reperfusion tachyarrhythmias (Kato et al., 2004 ) and paroxysmal supraventricular arrhythmias (Pritchett, 2004) . Several studies have also suggested that block of L-type and T-type channels may contribute to effective control of electrical remodeling occurring with atrial fibrillation and tachycardia (Fareh et al., 2001; Fareh et al., 1999; Ohashi et al., 2004) .
Like other calcium channel blockers, verapamil blocks both L-type and T-type channels in a state-dependent manner (Dilmac et al., 2004; Heady et al., 2001; Motoike et al., 1999; Nawrath and Wegener, 1997) . This feature is crucial from a clinical perspective, as the therapeutic effects of a drug are greatly influenced by the set of This article has not been copyedited and formatted. The final version may differ from this version. In the present study, we utilized both whole-cell voltage clamp and gating current measurements to systematically investigate the state-dependence of T-channel inhibition by verapamil. By expressing channels in HEK cells we were able to study verapamil block of T-channels with minimal contamination by endogenous conductances, a significant obstacle in native tissues.
Using whole-cell voltage-clamp we showed that verapamil exhibited a moderate use-dependence and induced a dramatic slowing of recovery kinetics, features also observed in L-channels (Dilmac et al., 2004; Johnson et al., 1996) . The slow recovery kinetics indicate that verapamil is capable of inhibiting T-channels over a time course much longer than that of the action potential, a feature which may be important in vivo.
However, the lack of a substantial drug effect on the time course of T-channel currents suggests that the kinetics of inhibition are distinct from those observed for other channel targets. Notably, verapamil did not accelerate current decay as has been reported in Lchannels (Dilmac et al., 2004; Johnson et al., 1996) and K + channels (Catacuzzeno et al., 1999; DeCoursey, 1995; Robe and Grissmer, 2000) , nor could the drug unbinding reaction be observed in the tail currents (data not shown), as in K + channels (Catacuzzeno et al., 1999; DeCoursey, 1995; Robe and Grissmer, 2000) .
The dependence on holding potential was strongly suggestive of high-affinity drug binding to an inactivated state of the channel. Consistent with that hypothesis, selective application of drug to inactivated channels produced a similar voltageThis article has not been copyedited and formatted. The final version may differ from this version. with the Ca 2+ -dependent inactivation process in these channels (Dilmac et al., 2004) .
The observation that verapamil block was independent of the current-eliciting potential was unexpected, but is consistent with results obtained for verapamil block of K + channels (DeCoursey, 1995; Robe and Grissmer, 2000) . One possibility is that verapamil binds outside of the transmembrane electric field. However, when we selectively increased the cytoplasmic concentration of charged drug by lowering intracellular pH, drug block was not substantially enhanced. This finding suggested that the primary active species of drug was likely the uncharged form, which may bind within This article has not been copyedited and formatted. The final version may differ from this version. the field (in the pore) with no observable voltage-dependence. A similar mechanism has been proposed for verapamil inhibition of K + channels (Catacuzzeno et al., 1999; DeCoursey, 1995; Robe and Grissmer, 2000) . Similarly, the absence of a voltage-dependence of block at potentials positive to -70 mV during long depolarizations in which inactivated channels were selectively exposed to drug ( Fig. 4D ) also argues against the charged drug as the primary active species.
Voltage-dependent partitioning of channels from closed states into inactivated states, rather than an interaction of the drug with the transmembrane field, likely accounts for the voltage-dependence of block observed at more negative potentials (Figs. 4B, 4D ).
The absence of a verapamil effect on ON gating currents and charge suggests that it inhibits currents simply by occlusion of the conduction pathway. Stabilization of a channel conformation by an antagonist is usually accompanied by alteration of gating currents, as in the cases of lidocaine inhibition of Na + channels (Sheets and Hanck, 2003) and nifedipine inhibition of L-type Ca 2+ channels (Hadley and Lederer, 1995) .
Because the T-channel appears to gate normally, even in the presence of a saturating concentration of verapamil (500 µ M), it is unlikely that the drug inhibits currents via a mechanism involving immobilization of the gating charge. However, it is possible that verapamil does allosterically stabilize a channel pore conformation in a manner that does not significantly affect voltage sensor movement. This article has not been copyedited and formatted. The final version may differ from this version. 
